BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25937441)

  • 1. Desmoteplase for late treatment of stroke: still in the dark.
    Hill MD; Menon BK
    Lancet Neurol; 2015 Jun; 14(6):560-1. PubMed ID: 25937441
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
    Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke).
    von Kummer R; Mori E; Truelsen T; Jensen JS; Grønning BA; Fiebach JB; Lovblad KO; Pedraza S; Romero JM; Chabriat H; Chang KC; Dávalos A; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A; Albers GW;
    Stroke; 2016 Dec; 47(12):2880-2887. PubMed ID: 27803391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke.
    Mori E; Minematsu K; Nakagawara J; Hasegawa Y; Nagahiro S; Okada Y; Truelsen T; Lindsten A; Ogawa A; Yamaguchi T;
    Stroke; 2015 Sep; 46(9):2549-54. PubMed ID: 26251244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoteplase as a potential treatment for cerebral ischaemia.
    Patel R; Ispoglou S; Apostolakis S
    Expert Opin Investig Drugs; 2014 Jun; 23(6):865-73. PubMed ID: 24766516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous thrombolysis in ischemic stroke: Therapeutic perspectives].
    Paris C; Derex L
    Rev Neurol (Paris); 2015 Dec; 171(12):866-75. PubMed ID: 26563662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain CT signs and the effect of alteplase after stroke.
    Larrue V
    Lancet Neurol; 2015 May; 14(5):458-60. PubMed ID: 25819483
    [No Abstract]   [Full Text] [Related]  

  • 8. Desmoteplase After Ischemic Stroke in Patients With Occlusion or High-Grade Stenosis in Major Cerebral Arteries.
    Lindsberg PJ; Caso V
    Stroke; 2016 Mar; 47(3):901-3. PubMed ID: 26846865
    [No Abstract]   [Full Text] [Related]  

  • 9. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversing stroke in the 2010s: lessons from Desmoteplase In Acute ischemic Stroke-2 (DIAS-2).
    Liebeskind DS
    Stroke; 2009 Sep; 40(9):3156-8. PubMed ID: 19608990
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolysis in acute ischaemic stroke.
    Barer D
    Lancet; 2012 Sep; 380(9847):1054; author reply 1054-5. PubMed ID: 22998709
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolysis in acute ischaemic stroke.
    Curtis D
    Lancet; 2012 Sep; 380(9847):1054; author reply 1054-5. PubMed ID: 22998707
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolysis in acute ischaemic stroke.
    Fatovich DM; MacDonald SP; Brown SG
    Lancet; 2012 Sep; 380(9847):1053; author reply 1054-5. PubMed ID: 22998706
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolysis in acute ischaemic stroke.
    Newman DH; Shreves AE
    Lancet; 2012 Sep; 380(9847):1053-4; author reply 1054-5. PubMed ID: 22998705
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolysis in acute ischaemic stroke.
    Smith B
    Lancet; 2012 Sep; 380(9847):1053; author reply 1054-5. PubMed ID: 22998704
    [No Abstract]   [Full Text] [Related]  

  • 16. A near-hanging patient with PTSD and acute stroke - an unusual condition for "off label" thrombolysis.
    Šupe S; Poljaković Z; Habek M; Pavliša G; Stojanović-Špehar S
    Psychiatr Danub; 2013 Jun; 25(2):185-7. PubMed ID: 23793286
    [No Abstract]   [Full Text] [Related]  

  • 17. In Vitro Examination of the Thrombolytic Efficacy of Desmoteplase and Therapeutic Ultrasound Compared with rt-PA.
    Roessler FC; Wang Z; Schumacher S; Ohlrich M; Kaps M; Menciassi A; Eggers J
    Ultrasound Med Biol; 2015 Dec; 41(12):3233-40. PubMed ID: 26349583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial Therapy in the Early Treatment of Acute Ischaemic Stroke.
    Kappelle LJ; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):1-2. PubMed ID: 26363971
    [No Abstract]   [Full Text] [Related]  

  • 19. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
    Reddrop C; Moldrich RX; Beart PM; Farso M; Liberatore GT; Howells DW; Petersen KU; Schleuning WD; Medcalf RL
    Stroke; 2005 Jun; 36(6):1241-6. PubMed ID: 15879331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical inquiries. When should patients with stroke receive thrombolytics?
    Adair G; Grant J; Pandhi N; Saunders R; Sadowsky I; West B; Kerns JW; Knight K; Richmond J
    J Fam Pract; 2004 Aug; 53(8):656, 658-9. PubMed ID: 15298842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.